• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

‘Natural’ for global bond yields to rise from here, say strategists

September 30, 2021 by David Barret Leave a Comment

September 30, 2021

By Hari Kishan

BENGALURU (Reuters) – Global sovereign yields will have only drifted modestly higher by this time next year, but most bond strategists polled by Reuters appear convinced the only way is up and the gap between short and long-term maturities is set to widen.

The latest quarterly poll results coincide with an unusually dramatic rise in Treasury yields following what most say is a decisive shift away from pandemic emergency policy by the world’s top central banks and rising concerns about inflation.

Their reluctance to forecast anything more than modest rises in yields may also be a reflection of the years spent by these same forecasters predicting such a return to normal only to be flattened by relentless demand – led by central banks – for government bonds.

But the sell-off in U.S. Treasuries this week that pushed yields up to levels not seen since mid-June suggests the government bond market is finally at an inflection point as investors realign their outlook with the Fed and other major central banks.

“Growth is above trend, inflation is high enough as of now and for the forecast horizon. With this kind of backdrop, it is but natural for interest rates generally in the developed markets to move higher,” said Arjun Vij, portfolio manager of J.P. Morgan Asset Management’s $1.15 billion Global Bond Fund.

“The Fed and markets are pretty close on when the first hike will be. It’s the pace of hikes” where there is room for markets to close the gap, Vij said.

The results of the poll, conducted Sept. 24-29, underscored that optimistic economic outlook, with 26 of 50 analysts, a 52% majority, saying a widening in U.S. two-year and 10-year Treasury spreads over the coming year was the more likely outcome.

While 11 said spreads would stay roughly steady, the remaining 13 forecast the gap to narrow.

(Reuters poll graphic on the major sovereign bond yields outlook: https://ift.tt/3kPwihU)

In the poll, over 60 bond strategists predicted the benchmark yield on the U.S. 10-year note would rise to 1.9% in 12 months, about 40 basis points higher than where it is now.

Benchmark yields in Germany, Britain and Japan were forecast to move up around 10 to 20 basis points during the same period.

(Reuters poll graphic on the U.S. Treasury yields outlook: https://ift.tt/3onTea6)

But there was no clear consensus among analysts on what would drive major sovereign yields in the short run.

Among those who answered a separate question, 24 of 49 said incoming economic data would have the most impact, while 23 chose forward guidance from central banks and the other two said COVID-19 developments and wrangling over the U.S. debt ceiling.

“We think the tapering of Fed asset purchases … is likely to have minimal market impact at this stage,” said Rick Rieder, chief investment officer of global fixed income at BlackRock, referring to expectations for a $10 billion reduction in U.S. Treasury purchases and $5 billion cut in mortgage-backed securities from its current $120 billion monthly buys.

“This is partly because the Fed has done a decent job of telegraphing when tapering is likely to begin, but more importantly it’s because the asset purchase reductions are likely to be trivial when seen in the context of how large the fixed income markets are today and how overwhelming the demand for income has become.”

(Reporting and polling by Prerana Bhat and Tushar Goenka; Editing by Ross Finley and Steve Orlofsky)

Source Link ‘Natural’ for global bond yields to rise from here, say strategists

David Barret
David Barret

Related posts:

  1. German services sector drives growth as recovery persists- PMI
  2. Hunted by the men they jailed, Afghanistan’s women judges seek escape
  3. Philip Morris seals deal to buy Vectura with 75% of shares tendered
  4. Over 40% of UK companies face recruitment difficulties – ONS

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Unethical Experiments: When Scientists Really Should Have Stopped What They Were Doing Immediately
  • The First Humans Were Hunted By Leopards And Weren’t The Apex Predators We Thought They Were
  • Earth’s Passage Through The Galaxy Might Be Written In Its Rocks
  • What Is An Einstein Cross – And Why Is The Latest One Such A Unique Find?
  • If We Found Life On Mars, What Would That Mean For The Fermi Paradox And The Great Filter?
  • The Longest Living Mammals Are Giants That Live Up To 200 Years In The Icy Arctic
  • Entirely New Virus Detected In Bat Urine, And It’s Only The 4th Of Its Kind Ever Isolated
  • The First Ever Full Asteroid History: From Its Doomed Discovery To Collecting Its Meteorites
  • World’s Oldest Pachycephalosaur Fossil Pushes Back These Dinosaurs’ Emergence By 15 Million Years
  • The Hole In The Ozone Layer Is Healing And On Track For Full Recovery In The 21st Century, Thanks To Science
  • First Sweet Potato Genome Reveals They’re Hybrids With A Puzzling Past And 6 Sets Of Chromosomes
  • Why Is The Top Of Canada So Sparsely Populated? Meet The “Canadian Shield”
  • Humans Are In The Middle Of “A Great Evolutionary Transition”, New Paper Claims
  • Why Do Some Toilets Have Two Flush Buttons?
  • 130-Year-Old Butter Additive Discovered In Danish Basement Contains Bacteria From The 1890s
  • Prehistoric Humans Made Necklaces From Marine Mollusk Fossils 20,000 Years Ago
  • Zond 5: In 1968 Two Soviet Steppe Tortoises Beat Humans To Orbiting Around The Moon
  • Why Cats Adapted This Defense Mechanism From Snakes
  • Mother Orca Seen Carrying Dead Calf Once Again On Washington Coast
  • A Busy Spider Season Is Brewing: Why This Fall Could See A Boom Of Arachnid Activity
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version